Radiotherapy of follicular lymphoma: Updated role and new rules

Current Treatment Options in Oncology

Volumn 15, Issue 2, 2014, Pages 262-268

  Yahalom, Joachim ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Follicular lymphoma; Involved field radiotherapy; Involved site radiotherapy; Low dose radiation; Low grade lymphoma; Marginal zone lymphoma; Nodal marginal zone lymphoma; Non Hodgkin lymphoma; Radiotherapy

Indexed keywords

RITUXIMAB;

ARTICLE; CANCER CONTROL; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; FOLLICULAR LYMPHOMA; HODGKIN DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; IONIZING RADIATION; LYMPH NODE IRRADIATION; LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MORTALITY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION FIELD; SURVIVAL TIME; CLINICAL TRIAL (TOPIC); DISEASE COURSE; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; RADIOTHERAPY; TREATMENT OUTCOME;

CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, NON-HODGKIN; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84902378082     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-014-0286-4     Document Type: Article

References (19)

1. Anderson T, Chabner BA, Young RC, et al. Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute. Cancer. 1982;50:2699-707. (Pubitemid 13220772)
2. Jacobson CA, Freedman AS. Early stage follicular lymphoma, current management and controversies. Curr Opin Oncol. 2012;24:475-9.
3. Tsang RW, Gospodarowicz MK. Low-grade non-hodgkin lymphomas. Semin Radiat Oncol. 2007;17:198-205. (Pubitemid 46963031)
4. Haas RL, Poortmans P, de Jong D, et al. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. J Clin Oncol. 2003;21:2474-80. (Pubitemid 46606327)
5. Zelenetz AD, et al: NCCN guidelines for non-Hodgkin lympphoma V.2013.2. 2013.
6. Pugh TJ, Ballonoff A, Newman F, et al. Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis. Cancer. 2010;116:3843-51.
7. Mac Manus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol. 1996;14:1282-90. (Pubitemid 26105537)
8. Campbell BA, Voss N, Woods R, et al. Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy. Cancer. 2010;116:3797-806.
9. Friedberg JW, Taylor MD, Cerhan JR, et al. Follicular lymphoma in the United States: first report of the national LymphoCare study. J Clin Oncol. 2009;27:1202-8.
10. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: long-term fol-low- up of no initial therapy. J Clin Oncol. 2004;22:1454-9. (Pubitemid 41103628)
11. Friedberg JW, Byrtek M, Link BK, et al. Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study. J Clin Oncol. 2012;30:3368-75.
12. Fuks Z, Kaplan H. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology. 1973;108:675-9.
13. • Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. Radiother Oncol. 2011;100:86-92. A practice-changing, randomized study on lowering RT dose in aggressive and indolent lymphomas.
14. • Illidge T, Specht L, Yahalom J, et al: Modern radiation therapy for nodal non Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Rad Oncol Biol Phys, 2014. The most detailed comprehensive guide for designing the RT field and choosing the dose - a consensus among international lymphoma radiation oncology experts.
15. Russo AL, Chen YH, Martin NE, et al. Low-dose involved-field radiation in the treatment of non-Hodgkin lymphoma: predictors of response and treatment failure. Int J Radiat Oncol Biol Phys. 2013;86:121-7.
16. • Hoskin PJ, Kirkwood AA, Popova B, et al: 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol, 2014. An important study on the limits of further lowering the RT dose for indolent lymphoma.
17. • Specht L: Radiotherapy for indolent lymphomas: how much is enough? Lancet Oncol, 2014. A well-conceived editorial on the limits and appropriateness of loweing the dose for potentially curative patients with indolent lymphoma.
18. Mac Manus MP, Hoppe RT. Overview of treatment of localized low-grade lymphomas. Hematol Oncol Clin North Am. 1997;11:901-18. (Pubitemid 27431152)
19. Specht L, Yahalom J, Illidge T, et al: Modern Radiation Therapy for Hodgkin Lymphoma: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys, 2013.